Carrier-free highly drug-loaded biomimetic nanosuspensions encapsulated by cancer cell membrane based on homology and active targeting for the treatment of glioma

Yueyue Fan,Yuexin Cui,Wenyan Hao,Mengyu Chen,Qianqian Liu,Yuli Wang,Meiyan Yang,Zhiping Li,Wei Gong,Shiyong Song,Yang Yang,Chunsheng Gao

DOI: https://doi.org/10.1016/j.bioactmat.2021.04.027

IF: 18.9

2021-12-01

Bioactive Materials

Abstract:Paclitaxel nanosuspensions with high drug-loading and without carrier.Biomimetic nanosuspensions wrapped by peptide-modified cancer cell membranes.Penetrate BBB and BBTB to transport drugs to glioma.Dual effects of active and homology targeting improve therapeutic efficiency.Nanosuspensions, as a new drug delivery system for insoluble drugs, are only composed of a drug and a small amount of stabilizer, which is dispersed in an aqueous solution with high drug-loading, small particle size, high dispersion, and large specific surface area. It can significantly improve the dissolution, bioavailability, and efficacy of insoluble drugs. In this study, paclitaxel nanosuspensions ((PTX)NS) were prepared by an ultrasonic precipitation method, with the characteristics of simple preparation and easy repetition. With the help of a homologous targeting mechanism, a kind of glioma C6 cancer cell membrane (CCM)-coated (PTX)NS was developed and modified with ^DWSW peptide to obtain ^DWSW-CCM-(PTX)NS with the functions of BBB penetration and tumor targeting. The results showed that the cancer cell membrane could effectively camouflage the nanosuspensions so that it was not cleared by the immune system and could cross the blood-brain-barrier (BBB) and selectively target tumor tissues. Cell uptake experiments and <em>in vivo</em> imaging confirmed that the uptake of ^DWSW-CCM-(PTX)NS by tumor cells and the distribution in intracranial gliomas increased. Cytotoxicity test and <em>in vivo</em> anti-glioma studies showed that ^DWSW-CCM-(PTX)NS could significantly inhibit the growth of glioma cells and significantly prolong the survival time of glioma-bearing mice. Finally, the cancer cell membrane coating endowed the nanosuspensions with the biological properties of homologous adhesion and immune escape. This study provides an integrated solution for improving the targeting of nanosuspensions and demonstrates the encouraging potential of biomimetic nanosuspensions applicable to tumor therapy.<span class="display"><span><ol class="links-for-figure"><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S2452199X21001961-ga1_lrg.jpg"><span class="anchor-text">Download : <span class="download-link-title">Download high-res image (478KB)</span></span></a></li><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S2452199X21001961-ga1.jpg"><span class="anchor-text">Download : <span class="download-link-title">Download full-size image</span></span></a></li></ol></span></span>

engineering, biomedical,materials science, biomaterials

What problem does this paper attempt to address?

The key problem that this paper attempts to solve is how to improve the targeted delivery efficiency of the poorly - soluble drug paclitaxel (PTX) to glioma, especially how to enable the drug to effectively penetrate the blood - brain barrier (BBB) and selectively target tumor tissues. Specifically, the research aims to overcome the following challenges by constructing a new type of bionic nano - suspension:

1. **Low drug solubility and bioavailability**: Paclitaxel is a poorly - soluble drug, and traditional drug - delivery methods are difficult to achieve its effective dissolution and absorption, thus limiting its efficacy.
2. **Poor physical stability of the drug - delivery system**: Nano - suspensions are prone to unstable phenomena such as sedimentation and aggregation in a liquid environment, affecting the drug - delivery effect.
3. **Immune system clearance and non - specific binding**: Once nanoparticles enter the blood, they are easily recognized and cleared by the reticuloendothelial system or mononuclear phagocytes, and are also prone to binding with non - specific proteins and biomolecules, interfering with their interaction with biological systems.
4. **Obstacles of the blood - brain barrier (BBB) and the blood - brain - tumor barrier (BBTB)**: Due to the existence of BBB and BBTB, many therapeutic drugs cannot effectively enter the brain, thus limiting their therapeutic effects on glioma.

To solve the above problems, researchers have developed a carrier - free, high - drug - loading bionic nano - suspension (DWSW - CCM - (PTX)NS) based on homology and active - targeting mechanisms. This nano - suspension is optimized through the following steps:

- **Preparation of paclitaxel nano - suspension ((PTX)NS)**: Prepared by the ultrasonic precipitation method, it has the characteristics of high drug - loading capacity, small particle size, high dispersibility and large specific surface area.
- **Coating with cancer cell membranes (CCM - (PTX)NS)**: The C6 glioma cell membrane is coated on the surface of the nano - suspension, endowing it with homologous targeting and immune - escape capabilities.
- **Modification of targeting ligands (DWSW - CCM - (PTX)NS)**: The DWSW peptide is used to modify the cancer cell membrane, enhancing its ability to penetrate the BBB and further improving its targeting of tumor tissues.

Through these improvements, the researchers have successfully improved the physical stability and targeting ability of the nano - suspension, enabling it to effectively penetrate the BBB and accumulate at the tumor site, thereby significantly inhibiting the growth of glioma cells and prolonging the survival time of tumor - bearing mice.

### Key Formulas

- **Particle Size Distribution**: \[ D_{\text{average}}=\frac{\sum_{i = 1}^{n}D_i\cdot N_i}{\sum_{i = 1}^{n}N_i}\]
where \(D_i\) is the diameter of the \(i\)-th particle and \(N_i\) is the number of the \(i\)-th particle.

- **Zeta Potential**: \[ \zeta=\frac{\eta\cdot v_e}{E}\]
where \(\eta\) is the medium viscosity, \(v_e\) is the electrophoretic velocity, and \(E\) is the applied electric field strength.

These improvement measures provide new ideas for improving the targeted delivery of poorly - soluble drugs and demonstrate the great potential of bionic nano - suspensions in tumor treatment.